We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biotech in a blink.
- Authors
Garber, Ken
- Abstract
The article highlights developments in therapeutics for retinal pathologies as of April 2010. It reference studies on the possible role of vascular endothelial growth factor (VEGF) in retinal disease. Among such efforts include the development of anti-VEGF antibodies for retinal diseases by researchers at Genentech led by Napoleone Ferrara and the VEGF Trap from Regeneron Pharmaceuticals. Other topics discussed are novel approaches to age-related macular degeneration (AMD) therapy, the potentials of gene and stem cell therapies.
- Subjects
THERAPEUTICS; RETINAL diseases; VASCULAR endothelial growth factors; RETINAL degeneration; FERRARA, Napoleone; REGENERON Pharmaceuticals Inc.; GENE therapy; STEM cell treatment
- Publication
Nature Biotechnology, 2010, Vol 28, Issue 4, p311
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0410-311